What’s Next for UCB S A ORDINARY SHARES BELGIUM (OTCMKTS:UCBJF) After Having Less Shares Shorted?

June 13, 2018 - By Louis Casey


The stock of UCB S A ORDINARY SHARES BELGIUM (OTCMKTS:UCBJF) registered a decrease of 40.16% in short interest. UCBJF’s total short interest was 123,800 shares in June as published by FINRA. Its down 40.16% from 206,900 shares, reported previously. With 200 shares average volume, it will take short sellers 619 days to cover their UCBJF’s short positions. The short interest to UCB S A ORDINARY SHARES BELGIUM’s float is 0.11%.

It closed at $78.18 lastly. It is down 0.00% since June 13, 2017 and is . It has underperformed by 12.57% the S&P500.

UCB SA, a biopharmaceutical company, focuses on the discovery and development of medicines and solutions for people living with severe diseases of the immune system or of the central nervous system. The company has market cap of $14.68 billion. The Company’s core products include Cimzia for ankylosing spondylitis, axial spondyloarthritis, Crohn??s disease, psoriatic arthritis, and rheumatoid arthritis; Keppra, Vimpat, and Briviact for epilepsy; and Neupro for Parkinson??s disease and restless legs syndrome. It has a 15.91 P/E ratio. The firm also offers Zyrtec and Xyzal for allergy; Venlafaxine ER for depressive and anxiety disorders; Nootropil for cognitive disorders; and Xyrem for narcolepsy.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.